Aquabounty Technologies

Penny Stocks Biotech Stocks Healthcare Stocks

$0.82

+0.04 (+5.24%)

As of Feb 8, 2:34 PM ET ·

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 3 38%

Sell 5 63%

Price Target

Analyst Price Target +2,468.8% upside

Low Target $14.27

Average Target $21.09

High Target $34.90

Current Price $0.82

Current
$0.82

Target
$21.09

$14.27 $21.09 avg $34.90

Scenario Analysis

Bear Case

$14.27

1,638.1%

Low target

Base Case

$21.09

+2,468.8%

Avg target

Bull Case

$34.90

+4,150.9%

High target

Risk/Reward

2.5x

Favorable

Price in Context

52-Week High

$21.04

-96.1% from high

52-Week Low

$17.58

+-95.3% from low

Target vs 52W High

$21.09

+0.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%